Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

PNAS 103 (41): 15184-15189

Copyright © 2006 by the National Academy of Sciences.

The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{varepsilon} inhibition

Marika Massaro*,{dagger}, Aida Habib{dagger},{ddagger}, Laura Lubrano§, Serena Del Turco§, Guido Lazzerini§, Todd Bourcier, Babette B. Weksler||, and Raffaele De Caterina**,{dagger}{dagger}

*Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, 73100 Lecce, Italy; {ddagger}Departments of Biochemistry and Internal Medicine, American University of Beirut, Beirut, Lebanon; §Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, 56124 Pisa, Italy; Department of Anesthesia, Brigham and Women's Hospital–Harvard Medical School, Boston, MA 02115; ||Weill Medical College of Cornell University, New York, NY 10021; and **Institute of Cardiology and Center of Excellence on Aging, "Gabriele d'Annunzio" University, 66100 Chieti, Italy


Figure 1
View larger version (31K):

[in a new window]
  		Fig. 1.. Inhibition of IL-1{alpha}- and PMA-mediated induction of COX-2 activity and protein by DHA. (A) HSVEC were preincubated in the absence (vehicle) or presence of 25 µmol/liter DHA for 0–48 h before stimulation with 10 ng/ml IL-1{alpha} for 12 h, then medium was collected and 6-ketoPGF1{alpha} measured by RIA. 6-ketoPGF1{alpha} is shown as percent of maximum response to IL-1{alpha} as a function of DHA preincubation time. Each bar represents the mean of eight determinations repeated in three separate experiments. *, P < 0.05; **, P < 0.01 vs. stimulated control. (B) HSVEC were preincubated with DHA, stimulated with 10 PMA for 12 h, then medium was collected and 6-ketoPGF1{alpha} measured and expressed as picogram per 1,000 cells for each of two DHA concentrations (25 and 50 µmol/liter). Each bar represents the mean of n = 8 determinations, repeated in three separate experiments. **, P < 0.01 vs. PMA alone. (C) HSVEC were preincubated with 25 µmol/liter DHA for 48 h, stimulated with 10 ng/ml IL-1{alpha} for 12 h, and then whole-cell lysates were analyzed by Western blot using antibodies specific for COX-1 and -2. Values of COX-2 are shown as percent of maximal control response (IL-1{alpha} alone). The blot depicted is representative of three similar ones. (D) HSVEC were preincubated with DHA for 48 h, stimulated with 10 nmol/liter PMA for 12 h, and cell lysates prepared and analyzed as in C. The blot depicted is representative of three similar ones. (E) HSVEC were preincubated with 25 µmol/liter for 48 h or 5 µmol/liter DPI, an inhibitor of NAD(P)H oxidase, for 30 min, then stimulated with 10 ng/ml IL-1{alpha} for 12 h, after which cells were fixed and immunostained as described in Materials and Methods. For C and D, densitometric values of COX-1 and -2 expression are reported as percent of maximal control response (IL-1{alpha} alone).

 

Figure 2
View larger version (12K):

[in a new window]
  		Fig. 2.. Involvement of ERK1/2 in the stimulated expression of COX-2 and effect of DHA on ERK1/2 activation. (A) HSVEC were treated with MEK1 inhibitor PD 98059 at indicated concentrations for 30 min, then 10 ng/ml IL-1{alpha} was added for 12 h. Whole-cell lysates were analyzed by Western blot using an antibody specific for COX-2. Values of COX-2 are reported as percent of maximal control response (IL-1{alpha} alone). The blot shown is representative of three similar ones. (B) HSVEC were treated with 10 µmol/liter PD 98059 for 30 min, and then 10 nmol/liter of PMA was added for 12 h. Whole-cell lysates were used for Western blot as in A. The blot depicted is representative of three similar ones. (C) HSVEC were pretreated with 10 µmol/liter PD 98059 for 30 min and then stimulated with 10 ng/ml IL-1{alpha}. After 1 h, nuclear proteins were prepared and assayed by Western blot using a specific antibody against the p65 NF-{kappa}B subunit. Values of p65 expression are reported as units of OD. The blot shown is representative of three similar ones. (D) HSVEC were pretreated with 25 µmol/liter DHA for 48 h and then stimulated with 10 ng/ml IL-1{alpha} for 30 min. Whole-cell lysates were prepared and used for Western blot analysis using a specific antibody against phosphorylated ERK1/2. To ascertain that the total level of the ERK1/2 remained unchanged, the same blots were reprobed with an anti-ERK1/2 antibody that recognizes both phosphorylated and nonphosphorylated forms. Values of ERK1/2 phosphorylation are reported as percent of maximal control response (IL-1{alpha} alone). This blot is representative of three similar ones.

 

Figure 3
View larger version (25K):

[in a new window]
  		Fig. 3.. Effect of DHA on ROS production and p47phox translocation induced by IL-1{alpha}. (A) HSVEC were pretreated with DPI, apocynin, or N-acetylcysteine for 30 min before IL-1{alpha} stimulation for 12 h. Whole-cell lysates were subjected to Western blot for COX-2. Values of COX-2 are reported as percent of maximal control response (IL-1{alpha} alone). The blot shown is representative of three similar ones. (B) HSVEC were pretreated with 25 µmol/ liter DHA for 48 h and then stimulated with 10 ng/ml IL-1{alpha} for 20 min. Subcellular fractions (soluble and particulate) were isolated and Western blots performed with an antibody specific for p47phox. Values are in units of OD. The blot depicted is representative of two similar ones. (C) HSVEC were pretreated with 25 µmol/liter DHA for 48 h and then stimulated with 10 ng/ml IL-1{alpha} for 1 h. Monolayers were then washed and loaded with reduced dichlorofluorescein for 30 min and imaged as described in Materials and Methods. (Upper) Original microphotographs, where sides of each square are 300 µm long. (Lower) Corresponding pseudocolor transformation of digitalized images, where the yellow color indicates a low generation of ROS, and darker colors indicate increased ROS generation, proportional to color intensity. (D) Quantitative analysis of the effect of DHA on ROS production by IL-1{alpha}, as measured by dichlorofluorescein (DCF) fluorescence emission. Subconfluent HSVEC were treated with DHA at 25 and 50 µmol/liter for 48 h in 96-well plates, stimulated with 10 ng/ml IL-1{alpha} for 1 h, and finally loaded with reduced DCF. After 30 min, fluorescence was measured with a plate reader as described. More than eight replicates were used for each condition. Results are expressed as arbitrary fluorescence units ± SD. *, P < 0.05; **, P < 0.01 vs. IL-1{alpha}-stimulated control. This experiment is representative of a series of four, with similar results.

 

Figure 4
View larger version (18K):

[in a new window]
  		Fig. 4.. Effects of DHA on PKC isoform translocations. (A) HSVEC were treated with Ro318220 for 30 min before IL-1{alpha} stimulation for 12 h. Whole-cell lysates were subjected to Western blot using an antibody specific for COX-2, and the value obtained at densitometric analysis is reported as percent of maximal control response (IL-1{alpha} alone). The blot is representative of three similar ones. (B) HSVEC were pretreated with PMA for 24 h before IL-1{alpha} stimulation for 12 h to down-regulate PKC activity. Whole-cell lysates were subjected to Western blot using an antibody specific for COX-2, as in A. The blot is representative of three similar ones. (C) HSVEC were pretreated as in B but then stimulated with PMA. The blot is representative of three similar ones. (D) HSVEC were pretreated with 25 µmol/liter DHA for 48 h and then stimulated with 10 nmol/liter PMA for 20 min. Subcellular fractions (soluble and particulate) were isolated, and Western blots were performed using anti-PKC{alpha}, -{varepsilon}, or -{zeta} antibodies. Values of PKC translocations are reported as units of OD at densitometric analysis. The blot is representative of two similar ones.

 

Figure 5
View larger version (16K):

[in a new window]
  		Fig. 5.. Proposed molecular model of dietary omega-3 fatty acid interference with IL-1 signaling pathways leading to COX-2 induction in EC. IL-1 binds to the IL-1 receptor type I (IL-1RI), which heterodimerizes with the IL-1 receptor accessory protein (IL-1RAcP). The IL-1R-associated kinases (IRAK) are then recruited and associated by the adapter proteins myeloid differentiation factor(MyD)88 and Toll-interacting protein (Tollip). The signaling pathway also includes the production of ROS (H2O2) through the activation of NAD(P)H oxidase by IRAK activation, as well as the activation of PKC, both contributing to NF-{kappa}B activation. DHA, by interfering with the production of ROS (through the inhibition of p47phox translocation and/or the scavenging of ROS by its multiple double bonds), would prevent the formation of H2O2, thus limiting all of the downstream cascade leading to COX-2 gene expression. Furthermore, DHA reduces PKC{varepsilon} activation, thus inhibiting ERK1/2 activation, also leading to NF-{kappa}B activation and COX-2 expression. TRAF, TNF receptor-associated factor; TAK-1, TGFbeta-activated kinase 1; TAB-2, TAK1-binding protein 2; NIK, NF-{kappa}B-inducing kinase; IKK, I{kappa}B kinase.

 

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882